JS

Jasmeet Singh Nijhawan

Active Director Director DIN 10449078
DIN 10449078 First appointment Jan 2024 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value •••• Premium profile

About Jasmeet Singh Nijhawan

Data last updated:

Jasmeet Singh Nijhawan is a Director at Helpkin Pharmaceuticals Private Limited (since 2024). The company operates in Paper. Helpkin Pharmaceuticals Private Limited reported revenue of ₹66.4 Lakh (FY 2025).

DIN 10449078
Primary Designation Director
Industry Paper
First Appointment 01 Jan 2024
Oldest Company Age 2 yrs
Largest company Helpkin Pharmaceuticals Private Limited · ₹66.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Jan 20242024₹66.4 Lakh (FY 2025)Active

Board colleagues of Jasmeet Singh Nijhawan

Directorship timeline

Open interactive timeline →
Helpkin Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Jasmeet Singh Nijhawan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jasmeet Singh Nijhawan

Jasmeet Singh Nijhawan currently holds 1 directorship: Helpkin Pharmaceuticals Private Limited (Director, since 01 Jan 2024, revenue ₹66.4 Lakh (FY 2025)).

Jasmeet Singh Nijhawan was first appointed on 01 Jan 2024 as Director at Helpkin Pharmaceuticals Private Limited.

The current boards of Jasmeet Singh Nijhawan's companies include Inderjeet Kaur Nijhawan (Helpkin Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available